Franklin FTSE South Korea ETF vs Stryker Corporation — how do they compare? Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.88B), while Stryker Corporation trades at $276.77 (market cap $105.64B). The key difference: Stryker Corporation is far larger — about 56.2× Franklin FTSE South Korea ETF's market cap, and Stryker Corporation pays a 1.28% dividend while Franklin FTSE South Korea ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Stryker Corporation for 20 Days on average.
| FLKR | SYK | |
|---|---|---|
Market Cap | $1.88B | $105.64B |
Volume | 709,775 | 1,918,844 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $388.35 |
52-Week Low | $27.09 | $269.75 |
Typical Hold Time | 15 Days | 20 Days |
Enterprise Value | — | $117.10B |
Dividend Yield | — | 1.28% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stryker (SYK) trades at $275.4, down 1.11% amid a bearish technical signal and negative news flow. The company maintains strong profitability with a 14.43% net margin and a 71% analyst buy rating, but faces headwinds from a manufacturing issue disclosure that triggered an 8.8% stock drop on September 8, 2026. Q3 2026 earnings are due October 29, 2026, following a mixed earnings history with a recent miss in Q1 2026.
The stock presents a divergence between solid fundamentals and near-term sentiment risks. The consensus price target of $368.11 implies significant upside, but ongoing legal investigations and operational challenges pose risks to investor confidence. Earnings growth and resolution of manufacturing issues are critical for sustained recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →